SureTrader
Home > Boards > US Listed > Biotechs > Rosetta Genomics Ltd (ROSG)

RSI still at 66.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Penny Gold Mine Member Profile
 
Followed By 219
Posts 7,049
Boards Moderated 2
Alias Born 12/14/09
160x600 placeholder
Rosetta Genomics Selected by a Global Pharmaceutical Company to Supply FISH Testing Services for Clinical Study in Prostate C... "Business Wire" - 8/24/2016 9:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/22/2016 4:50:01 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/9/2016 6:05:28 AM
Rosetta Genomics Expands Molecular Diagnostics Test Menu with Launch of OncoGxSelect™ from Admera Health "Business Wire" - 8/4/2016 8:15:00 AM
Rosetta Expands Managed Care Coverage with New Preferred Provider Agreement with Galaxy Health Network for Entire Suite of Di... "Business Wire" - 8/2/2016 8:15:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/1/2016 3:14:38 PM
Rosetta Genomics Receives U.S. Patent Allowance for microRNA-based Ovarian Cancer Treatment "Business Wire" - 7/11/2016 8:59:00 AM
Rosetta Genomics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference "Business Wire" - 7/6/2016 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/24/2016 4:09:16 PM
Rosetta Expands Managed Care Coverage with New Preferred Provider Agreement for Entire Suite of Diagnostic Tests and Services "Business Wire" - 6/23/2016 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/21/2016 4:10:27 PM
Rosetta Genomics Receives Approval from New York State for HEME FISH-based Assays "Business Wire" - 6/21/2016 9:12:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/26/2016 11:04:07 AM
Rosetta Genomics Announces Publication of Data Confirming Analytical Validity of its Novel Thyroid Nodule Classification Assay "Business Wire" - 5/26/2016 7:00:00 AM
Rosetta Genomics Receives Approval from New York State for Four PCR-Based Assays "Business Wire" - 5/23/2016 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/19/2016 5:13:14 PM
Rosetta Genomics Reports 2016 First Quarter Financial Results "Business Wire" - 5/19/2016 8:00:00 AM
Rosetta Genomics to Host 2016 First Quarter Financial Results and Business Update Conference Call on May 19, 2016 "Business Wire" - 5/16/2016 8:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 3/31/2016 6:01:48 AM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) "Edgar (US Regulatory)" - 3/30/2016 5:58:50 PM
Securities Registration (foreign Private Issuer) (f-3) "Edgar (US Regulatory)" - 3/23/2016 4:46:34 PM
Rosetta Genomics Reports 2015 Full Year Financial Results "Business Wire" - 3/23/2016 4:05:00 PM
Rosetta Genomics to Host Business Update and 2015 Year-End Financial Results Conference Call on March 23, 2016 "Business Wire" - 3/17/2016 8:30:00 AM
Statement of Beneficial Ownership (sc 13d) "Edgar (US Regulatory)" - 3/4/2016 4:06:17 PM
Rosetta Genomics Appoints Ana C. Ward as Executive Vice President, Legal and Corporate Development "Business Wire" - 2/29/2016 9:00:00 AM
Penny Gold Mine   Thursday, 05/31/12 08:32:15 AM
Re: None
Post # of 1868 
RSI still at 66.

needs to cool off still for next run.IMO

11 may be enough

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist